| Drug Name |
Mometasone furoate monohydrate |
| Drug ID |
BADD_D01492 |
| Description |
Mometasone furoate is a corticosteroid drug that can be used for the treatment of asthma, rhinitis, and certain skin conditions[FDA Label][F4292,F4295]. It has a glucocorticoid receptor binding affinity 22 times stronger than [dexamethasone] and higher than many other corticosteroids as well[A176906]. Mometasone furoate is formulated as a dry powder inhaler, nasal spray, and ointment for its different indications[FDA Label][F4292,F4295]. |
| Indications and Usage |
There are 3 formulations of mometasone furoate with various indications. The inhaler is indicated for prophylaxis of asthma in patients ≥4 years[FDA Label]. The nasal spray is indicated for treating nasal symptoms of allergic rhinitis in patients ≥2 years, treating symptoms of nasal congestion from seasonal allergic rhinitis in patients ≥2 years, treating nasal polyps in patients ≥18 years, and prophylaxis of seasonal allergic rhinitis in patients ≥12 years[F4292]. The ointment is indicated for symptomatic treatment of dermatitis and pruritis in patients ≥2 years[F4295]. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
R03BA07; D07XC03; R01AD09; D07AC13 |
| DrugBank ID |
DB14512
|
| KEGG ID |
D03325
|
| MeSH ID |
D000068656
|
| PubChem ID |
9893453
|
| TTD Drug ID |
D03HYX
|
| NDC Product Code |
82442-999; 22552-0021; 58175-0551; 64918-0331; 50909-5152; 76162-134; 63190-0320; 63190-0690; 53104-7663; 0363-2060; 64918-1912; 15308-2710 |
| UNII |
MTW0WEG809
|
| Synonyms |
Mometasone Furoate | Furoate, Mometasone | Nasonex | Mometasone Furoate Monohydrate | Furoate Monohydrate, Mometasone | Monohydrate, Mometasone Furoate | Asmanex Twisthaler | Twisthaler, Asmanex | Asmanex | Rinelon | Elocon | Sch 32088 | Sch-32088 | Sch32088 | Mometasone |
